Cargando…

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed intraoperative blood sampling from ovarian veins of stage I epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiland, Florian, Lokman, Noor A., Klingler-Hoffmann, Manuela, Jobling, Thomas, Stephens, Andrew N., Sundfeldt, Karin, Hoffmann, Peter, Oehler, Martin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545354/ https://www.ncbi.nlm.nih.gov/pubmed/33102207 http://dx.doi.org/10.3389/fonc.2020.01767

Ejemplares similares

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer
por: Arentz, Georgia, et al.
Publicado: (2023)

Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2021)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
por: Weiland, Florian, et al.
Publicado: (2012)

Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
por: Weiland, Florian, et al.
Publicado: (2012)

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
por: Acland, Mitchell, et al.
Publicado: (2020)

Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors
por: Barone, Angela, et al.
Publicado: (2020)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
por: Partheen, Karolina, et al.
Publicado: (2011)

Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
por: Kristjansdottir, Björg, et al.
Publicado: (2013)

Antibody Phage Display Assisted Identification of Junction Plakoglobin as a Potential Biomarker for Atherosclerosis
por: Cooksley-Decasper, Seraina, et al.
Publicado: (2012)

Cross-Talk between Adherens Junctions and Desmosomes Depends on Plakoglobin
por: Lewis, Jani E., et al.
Publicado: (1997)

Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis
por: Lokman, Noor A., et al.
Publicado: (2013)

Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis
por: Lokman, Noor A., et al.
Publicado: (2012)

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
por: Ricciardelli, Carmela, et al.
Publicado: (2017)

Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
por: Khetan, Riya, et al.
Publicado: (2022)

MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia
por: Zhang, Chao, et al.
Publicado: (2016)

Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets
por: Spethmann, Tanja, et al.
Publicado: (2021)

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
por: Enroth, Stefan, et al.
Publicado: (2019)

Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers
por: Mukherjee, Shuvolina, et al.
Publicado: (2021)

S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer
por: Noye, Tannith M., et al.
Publicado: (2018)

Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer
por: Kang, Sung-Woog, et al.
Publicado: (2021)

A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer
por: Lee, Eunice, et al.
Publicado: (2020)

The Amino-terminal Domain of Desmoplakin Binds to Plakoglobin and Clusters Desmosomal Cadherin–Plakoglobin Complexes
por: Kowalczyk, Andrew P., et al.
Publicado: (1997)

External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
por: Partheen, Karolina, et al.
Publicado: (2009)

Plakoglobin: Role in Tumorigenesis and Metastasis
por: Aktary, Zackie, et al.
Publicado: (2012)

Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer
por: Gyllensten, Ulf, et al.
Publicado: (2022)

Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers
por: Kristjansdottir, Björg, et al.
Publicado: (2012)

Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53
por: Alaee, Mahsa, et al.
Publicado: (2016)

A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer
por: Enroth, Stefan, et al.
Publicado: (2018)

Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma
por: Chen, Ke, et al.
Publicado: (2021)

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
por: Ricciardelli, Carmela, et al.
Publicado: (2013)

Plakoglobin is a mechanoresponsive regulator of naive pluripotency
por: Kohler, Timo N., et al.
Publicado: (2023)

RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
por: Xie, Biao, et al.
Publicado: (2022)

Sociodemographic disparities in targeted therapy in ovarian cancer in a national sample
por: Amin, Saber A., et al.
Publicado: (2023)

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome
por: Wang, Wanqi, et al.
Publicado: (2021)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Mutational Landscape for Indian Hereditary Breast and Ovarian Cancer Cohort Suggests Need for Identifying Population Specific Genes and Biomarkers for Screening
por: Kadri, Mohammed Shaad N., et al.
Publicado: (2021)

Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer
por: Wang, Kaili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_661brmksgklvq8md7n8o4o5g60